home ver. 2.3. site index contact us

Message from the CEO
How We Work
Business Integrity
History of Schering-Plough
Management Team
Schering-Plough Worldwide
Speeches & Presentations
The Schering-Plough Foundation
Diversity & Inclusion
Supplier Registration
Diversity Colleague Demographics

Management Biographies

STANLEY F. BARSHAY
Chairman, Consumer Health Care
Schering-Plough Corporation
Berkeley Heights, New Jersey

Stanley F. Barshay is chairman, Consumer Health Care, for Schering-Plough Corporation.

Barshay joined Schering-Plough in July 2003. He has an extensive background in health care and related consumer products with American Home Products Corporation (now Wyeth). He was promoted in 1987 to senior vice president overseeing that company's consumer businesses and also served on its finance and operations committees. During his career with American Home Products, Barshay also was president of several of the company's subsidiaries, including Boyle-Midway Household Products Corporation and Whitehall Laboratories. Barshay retired from Wyeth in 1997 and has remained active in the health care arena.

Barshay graduated from Long Island University with a B.S. degree in business administration. He also studied at the New York University Graduate School of Business.

Barshay serves on the board of trustees of Long Island University and J.C.C.A. He is also on the Council of Overseers for the Arnold & Marie Schwartz College of Pharmacy and Health Sciences and serves on the board of directors of Bed, Bath & Beyond, Inc.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.

 

Spotlight On

Combination Brochure

Brochure on the Combination

Basic Facts and Figures
•  World Headquarters:
2000 Galloping Hill Road, Kenilworth, N.J. 07033-0530
•  Chairman and CEO:
Fred Hassan
Number of employees:
55,000
Net sales (2007):
$12.7 billion
Business operations in more than:
140 countries
Largest-selling products:
VYTORIN*, ZETIA*, REMICADE, NASONEX.
R&D investment (2007):
$2.9 billion
Areas of research:
cardiovascular disease, central nervous system disorders, immunology and infectious disease, oncology, respiratory diseases and women's health

*VYTORIN and ZETIA are managed through a joint venture with Merck & Co., Inc. Schering-Plough accounts for the joint venture under the Equity method. Total cholesterol joint venture sales were $5.2 billion in 2007.
 
                                      © 2003-2008 Schering-Plough Corporation.
                 Please see our legal notice, privacy policy and forward-looking statement.
Schering-Plough Schering-Plough skip to content Schering-Plough